# Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

> **NCT03988231** · PHASE4 · WITHDRAWN · sponsor: **University of Utah**

## Conditions studied

- Venous Thromboembolism
- Bleeding as Surgical Complication (Treatment)
- Deep Venous Thrombosis
- Pulmonary Embolism

## Interventions

- **DRUG:** Receipt of enoxaparin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03988231
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-07
- **Primary completion:** 2022-06
- **Final completion:** 2023-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding was not received.
- **Last updated:** 2021-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03988231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03988231, "Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03988231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*